Dan Roden
Faculty Member
Last active: 3/24/2020

Using Human 'Experiments of Nature' to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors.

Jerome RN, Pulley JM, Roden DM, Shirey-Rice JK, Bastarache LA, R Bernard G, B Ekstrom L, Lancaster WJ, Denny JC
Drug Saf. 2018 41 (3): 303-311

PMID: 29185237 · PMCID: PMC5828879 · DOI:10.1007/s40264-017-0616-0

MeSH Terms (13)

Cholesterol, LDL Enzyme Inhibitors Female Genotype Humans Hypercholesterolemia Male Phenotype Polymorphism, Single Nucleotide Product Surveillance, Postmarketing Proprotein Convertase 9 Risk Factors Spinal Dysraphism

Connections (2)

This publication is referenced by other Labnodes entities: